Mode
Text Size
Log in / Sign up
N/A N=30 Randomized Single-blind Treatment

Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population

Overactive Bladder · Voiding Disorders · Incontinence, Urinary

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcome: Primary: Dysfunctional Voiding Symptom Score — 8; 11 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
parasacral transcutaneous electrical nerve stimulation (PTENS) (Device); Standard Urotherapy (Other)
Age
Pediatric · 6+ yrs
Sex
All
Sponsor
University of Utah
Primary completion
Jun 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Dysfunctional Voiding Symptom Score
8; 11
PRIMARY
Voiding Diary and the Number of Episodes of Incontinence Per Day
2; 1; 1; 0.5
SECONDARY
Secondary Outcome. Review of Adverse Events.
0; 2

Summary

Pilot study for determining feasibility of home parasacral transcutaneous electrical nerve stimulation in treatment of urinary urgency and incontinence.

Eligibility Criteria

Inclusion Criteria

  • Toilet trained (age 6) to age 17
  • Diagnosis of urinary dysfunction, voiding dysfunction, overactive bladder, urgency incontinence, nocturnal enuresis. (These patients may also have an element of bowel dysfunction; however, we will not include a patient who had ONLY bowel dysfunction and NOT a voiding dysfunction).

Exclusion Criteria

  • Known neurologic diagnosis - such as myelomeningocele, caudal regression
  • Known seizure disorder
  • Age 17
  • Lack of follow-up within 6 months of treatment
  • Pacemaker, vagal nerve stimulator, or other implanted electrical device
  • Intolerance of electrical nerve stimulation
  • Pregnancy
  • Implanted metal hardware
  • Open sores or wounds over the sacral area
  • Currently catheterizing for bladder drainage
  • Known anatomic lower urinary tract abnormality (may be congenital or iatrogenic)
  • Bowel only voiding dysfunction (Constipation ICD-10 K59.00)
  • Non-English speaking families
  • Families with health literacy precluding completion of questionnaires and voiding diaries
  • Concurrent use of anticholinergics, alpha blockers or beta agonists for urologic treatments
  • Untreated urinary tract infection
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04570605). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search